EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Heightened Epstein-Barr virus immunity and potential cross-reactivities in multiple sclerosis

Olivia G Thomas, Tracey A Haigh, Deborah Croom-Carter, Alison Leese, Yolanda Van Wijck, Michael R Douglas, Alan Rickinson, Jill M Brooks, Graham S Taylor iD

PLOS Pathogens · 2024

DOI: 10.1371/journal.ppat.1012177 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, 2024. Verfasst von Olivia G Thomas und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, United Kingdom. Hauptthemen laut MEDLINE: Herpesvirus 4, Human, Epstein-Barr Virus Infections, Antibodies, Viral. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Multiple Sclerosis Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Epstein-Barr virus (EBV) is a likely prerequisite for multiple sclerosis (MS) but the underlying mechanisms are unknown. We investigated antibody and T cell responses to EBV in persons with MS (pwMS), healthy EBV-seropositive controls (HC) and post-infectious mononucleosis (POST-IM) individuals up to 6 months after disease resolution. The ability of EBV-specific T cell responses to target antigens from the central nervous system (CNS) was also investigated.

Methods

Untreated persons with relapsing-remitting MS, POST-IM individuals and HC were, as far as possible, matched for gender, age and HLA-DRB1*15 : 01 . EBV load was determined by qPCR, and IgG responses to key EBV antigens were determined by ELISA, immunofluorescence and Western blot, and tetanus toxoid antibody responses by multiplex bead array. EBV-specific T cell responses were determined ex vivo by intracellular cytokine staining (ICS) and cross-reactivity of in vitro -expanded responses probed against 9 novel Modified Vaccinia Ankara (MVA) viruses expressing candidate CNS autoantigens.

Results

EBV load in peripheral blood mononuclear cells (PBMC) was unchanged in pwMS compared to HC. Serologically, while tetanus toxoid responses were unchanged between groups, IgG responses to EBNA1 and virus capsid antigen (VCA) were significantly elevated (EBNA1 p = 0 . 0079 , VCA p = 0 . 0298 ) but, importantly, IgG responses to EBNA2 and the EBNA3 family antigens were also more frequently detected in pwMS (EBNA2 p = 0 . 042 and EBNA3 p = 0 . 005 ). In ex vivo assays, T cell responses to autologous EBV-transformed B cells and to EBNA1 were largely unchanged numerically, but significantly increased IL-2 production was observed in response to certain stimuli in pwMS. EBV-specific polyclonal T cell lines from both MS and HC showed high levels of autoantigen recognition by ICS, and several neuronal proteins emerged as common targets including MOG, MBP, PLP and MOBP.

Discussion

Elevated serum EBV-specific antibody responses in the MS group were found to extend beyond EBNA1, suggesting a larger dysregulation of EBV-specific antibody responses than previously recognised. Differences in T cell responses to EBV were more difficult to discern, however stimulating EBV-expanded polyclonal T cell lines with 9 candidate CNS autoantigens revealed a high level of autoreactivity and indicate a far-reaching ability of the virus-induced T cell compartment to damage the CNS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Herpesvirus 4, HumanEpstein-Barr Virus InfectionsAntibodies, ViralHumansFemaleMaleAdultMiddle AgedCross ReactionsMultiple SclerosisT-LymphocytesMultiple Sclerosis, Relapsing-RemittingAntigens, ViralViral LoadInfectious MononucleosisEpstein-Barr Virus Nuclear AntigensImmunoglobulin G

Substanzen

Antibodies, ViralAntigens, ViralEpstein-Barr Virus Nuclear AntigensImmunoglobulin G

Autor:innen und Institutionen

  • Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, United Kingdom.
  • Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, United Kingdom.
  • School of Biological Sciences, University of Birmingham, Edgbaston, United Kingdom.
  • Dudley Group of Hospitals NHS Foundation Trust, Dudley, United Kingdom.
  • Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.

ORCID-Profile: Graham S Taylor

Förderung

  • Wellcome Trust
  • Multiple Sclerosis Society

Zitieren

APA

Thomas, O. G., Haigh, T. A., Croom-Carter, D., Leese, A., Van Wijck, Y., Douglas, M. R., Rickinson, A., Brooks, J. M., & Taylor, G. S. (2024). Heightened Epstein-Barr virus immunity and potential cross-reactivities in multiple sclerosis. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1012177

Vancouver

Thomas OG, Haigh TA, Croom-Carter D, Leese A, Van Wijck Y, Douglas MR, et al. Heightened Epstein-Barr virus immunity and potential cross-reactivities in multiple sclerosis. PLOS Pathogens. 2024. doi:10.1371/journal.ppat.1012177

BibTeX
@article{Thomas2024,
  author = {Thomas, Olivia G and Haigh, Tracey A and Croom-Carter, Deborah and Leese, Alison and Van Wijck, Yolanda and Douglas, Michael R and Rickinson, Alan and Brooks, Jill M and Taylor, Graham S},
  title = {Heightened Epstein-Barr virus immunity and potential cross-reactivities in multiple sclerosis},
  journal = {PLOS Pathogens},
  year = {2024},
  doi = {10.1371/journal.ppat.1012177}
}
Kostenlos starten →